Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, May 2002, p. 639-648, Vol. 9, No. 3
1071-412X/02/$04.00+0 DOI: 10.1128/CDLI.9.3.639-648.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Charles F. Longer,1,
Robert M. Scott,3 David W. Vaughn,5,
and Khin Saw Aye Myint5
Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910,1 Novavax, Inc., Rockville, Maryland 20852,2 Walter Reed/AFRIMS Research UnitNepal, Kathmandu, Nepal,3 Genelabs Technologies, Inc., Redwood City, California 94063,4 Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand5
Received 4 December 2001/ Returned for modification 17 January 2002/ Accepted 25 January 2002
We developed a quantitative enzyme immunoassay (EIA) for antibody to hepatitis E virus (HEV) by using truncated HEV capsid protein expressed in the baculovirus system to improve seroepidemiology, to contribute to hepatitis E diagnosis, and to enable vaccine evaluations. Five antigen lots were characterized; we used a reference antiserum to standardize antigen potency. We defined Walter Reed antibody units (WR U) with a reference antiserum by using the four-parameter logistic model, established other reference pools as assay standards, and determined the conversion factor: 1 WR U/ml = 0.125 World Health Organization unit (WHO U) per ml. The EIA performed consistently; median intra- and intertest coefficients of variation were 9 and 12%, respectively. The accurate minimum detection limit with serum diluted 1:1,000 was 5.6 WR U/ml; the test could detect reliably a fourfold antibody change. In six people followed from health to onset of hepatitis E, the geometric mean antibody level rose from 7.1 WR U/ml to 1,924.6 WR U/ml. We used the presence of 56- and 180-kDa bands by Western blotting as a confirmatory test and to define true-negative and -positive serum specimens. A receiver-operating characteristics plot identified 30 WR U/ml as an optimum cut-point (sensitivity, 86%; specificity, 89%). The EIA detected antibody more sensitively than a commercially available test. The EIA was transferred to another laboratory, where four operators matched reference laboratory results for a panel of unknowns. Quantitation of antibody to HEV and confirmation of its specificity by Western blotting make HEV serology more meaningful.
Present address: Tanox, Inc., Houston, TX 77025.
Present address: Chattanooga Unit, University of Tennessee College of Medicine, Chattanooga, TN 37403.
Present address: Department of Virus Diseases, Walter Reed Army Institute of Research, Silver Spring, MD 20910.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»